Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... program, which is currently focused on the treatment of Hepatitis C infection and prostate cancer," said Stephen T. Isaacs, Aduro's President and Chief Executive Officer. "We ... Listeria is an ideal delivery platform to enable the human immune system to recognize a specificantigen and rally an attack against it. The Listeria approach overcomes many of the ...
2009 NOV 23 ... from the United States, "Several studies have examined serum creatinine as a marker for prostate cancer stage, recurrence, and prognosis. We evaluated whether serum creatinine ... association in other populations, including any interrelationship with serum prostate-specificantigen. (Cancer Epidemiol Biomarkers Prev 2009;18(10):2643-9)." Weinstein ...
2009 NOV 23 ... Greene and colleagues published their study in the Journal of Urology (Prostate Specific Antigen Best Practice Statement: 2009 Update. Journal of Urology, 2009;182(5):2232-2241). ...
2009 NOV 23 ... Investigators publish new data in the report 'Prostate cancer detection: the value of performing an MRI before a biopsy.' According to recent ... recent research published in the journal Acta Radiologica, "In recent years, prostate-specificantigen (PSA) screening has been widely performed. As a result, patients who need to ...
2009 NOV 23 ... of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specificantigen (PSA) levels in men may be caused by a hormone normally occurring in ...
Subject: Wake Forest University Baptist Medical Center
2009 NOV 23 ... A report, 'Psychological distress and prostate specific antigen levels in men with and without prostate cancer,' is newly published data in Brain, ...
2009 NOV 23 ... population included consecutive patients who underwent prostate biopsy for increased prostate specific antigen and/or abnormal digital rectal examination at Atlanta Veterans Affairs Medical Center. ...
2009 NOV 23 ... the report, 'PSA doubling time as a predictive factor on repeat biopsy for detection of prostate cancer,' have been published. According to recent research from Japan, "Detection of ... cancer needs a biopsy of the prostate. Suspecting cancer from an increase in prostate-specificantigen (PSA) has a high negative rate at an initial prostate biopsy." ...
2009 NOV 23 ... 70 years have a higher risk of prostate cancer and poorer survival in the early and late prostate specific antigen eras. A cohort of 4,561 men who underwent radical prostatectomy were stratified into 3 ...
2009 NOV 23 ... and TLR-4). Our previous study concluded that gp96 purified from various rat and human prostate cancers is differentially glycosylated based on the amino and neutral monosaccharide ... Research findings, 'Sialic acid content of tissue-specific gp96 and its potential role in modulating gp96-macrophage interactions,' are discussed ... occur for an immune response to be generated is the interaction between gp96 and the antigen presenting cell (APC) surface receptors (CD91, SR-A, TLR-2, and TLR-4). Our previous ...
2009 NOV 23 ... Current study results from the report, 'HE3235 inhibits growth of castration-resistant prostate cancer,' have been published. According to recent research from the United States, ... were injected intratibially with C4-2B CaP cells and treated with HE3235. Serum prostate-specificantigen (PSA) levels, tumor volume, immunohistochemistry, gene expression, and levels of ...
2009 NOV 23 ... New investigation results, 'A review of prostate-specificantigen screening prevalence and risk perceptions for first-degree relatives of ...
2009 NOV 23 ... pain syndrome would recognize peptides derived from the normal self-prostatic proteins prostate specific antigen and prostatic acid phosphatase," researchers in the United States report. ...
2009 NOV 23 ... accuracy of available tests." "This paper assesses whether the use of prostate specific antigen kinetics has a practical use in the contemporary urological setting. A Medline ...
2009 NOV 23 ... Berlin, Germany conducted a study "To show discriminative power between patients with prostate cancer (PCa) and those with ''no evidence of malignancy'' using ''benign'' ... (PCa) and those with ''no evidence of malignancy'' using ''benign'' prostate-specificantigen (bPSA) and the new automated Access benign prostatic hyperplasia-associated ...
2009 NOV 23 ... prostate biopsy result and Gleason sum. After adjusting for age, race, body mass index, prostate specific antigen, digital rectal examination, family history, previous prostate biopsy and comorbidity ...
2009 NOV 23 ... of biochemical recurrence and all cause mortality in patients with persistently elevated prostate specific antigen after radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort. ...
2009 NOV 23 ... New Mayo Clinic research studied the association between prostate-specificantigen (PSA) levels and prostate size and found that routine annual evaluation ...
2009 NOV 23 ... research from the United States, "Although there is uncertainty about the effect of prostate-specificantigen (PSA) screening on the rate of prostate cancer death, there is little ...
2009 NOV 23 ... Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, announced the initiation of a Phase 1/2 clinical trial of its lead candidate ... in Phase 3 clinical trials and the compound has demonstrated reduction in prostate-specificantigen (PSA) levels. Notably, TOK-001 is the first investigational new drug that ...
